Definium Therapeutics (DFTX) Other financing activities (2021 - 2026)
Definium Therapeutics (DFTX) posted quarterly Other financing activities of $1.2 million for Q1 2026, up 404.64% year-over-year from $237000.0 in Q1 2025, and down 99.54% quarter-over-quarter from $257.9 million in Q4 2025.
Definium Therapeutics (DFTX) Other financing activities (2021 - 2026) Analysis & Trends
Definium Therapeutics (DFTX) has reported Other financing activities for 6 consecutive years, with $1.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other financing activities rose 404.64% year-over-year to $1.2 million; the TTM figure through Mar 2026 stood at $259.8 million (up 4.54% YoY), while the FY2025 annual figure was $258.9 million, up 3.54% from the prior year.
- Other financing activities eased to $1.2 million in Q1 2026 per DFTX's latest filing, from $257.9 million in the prior quarter.
- Across five years, Other financing activities topped out at $257.9 million in Q4 2025 and bottomed at -$688000.0 in Q4 2023.
- Historically, Other financing activities has averaged $43.9 million across 5 years, with a median of $1.0 million in 2025.
- Annual changes were most pronounced in 2023 — Other financing activities tumbled 104.04% — and 2024, when it surged 35793.02%.
- Definium Therapeutics' Other financing activities stood at $17.0 million in 2022, then sank by 104.04% to -$688000.0 in 2023, then soared by 35793.02% to $245.6 million in 2024, then advanced by 5.0% to $257.9 million in 2025, then sank by 99.54% to $1.2 million in 2026.
- Business Quant data shows DFTX's Other financing activities at $1.2 million in Q1 2026, $257.9 million in Q4 2025, and $818000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Definium Therapeutics | 4.72 Bn | 4.72 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 801.17 Mn |
| Jun 30, 2026 | 801.17 Mn |
| Mar 31, 2026 | 1.20 Mn |
| Mar 31, 2026 | 1.20 Mn |
| Dec 31, 2025 | 257.85 Mn |
| Dec 31, 2025 | 257.85 Mn |
| Sep 30, 2025 | 818,000.00 |
| Sep 30, 2025 | 818,000.00 |
| Jun 30, 2025 | -51,000.00 |
| Jun 30, 2025 | -51,000.00 |
| Mar 31, 2025 | 237,000.00 |
| Mar 31, 2025 | 237,000.00 |
| Dec 31, 2024 | 245.57 Mn |
| Dec 31, 2024 | 245.57 Mn |
| Jun 30, 2024 | 2.73 Mn |
| Jun 30, 2024 | 2.73 Mn |
| Mar 31, 2024 | 1.70 Mn |
| Mar 31, 2024 | 1.70 Mn |
| Dec 31, 2023 | -688,000.00 |
| Dec 31, 2023 | -688,000.00 |